Ignite Creation Date:
2025-12-25 @ 1:27 AM
Ignite Modification Date:
2026-01-03 @ 8:31 AM
Study NCT ID:
NCT02322593
Status:
COMPLETED
Last Update Posted:
2021-12-20
First Post:
2014-12-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase III Study of TAS-118 Plus Oxaliplatin Versus S-1 Plus Cisplatin in Patients With Advanced Gastric Cancer
Sponsor:
Taiho Pharmaceutical Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-12
Start Date Type:
ACTUAL
Primary Completion Date:
2019-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-05
Completion Date Type:
ACTUAL
First Submit Date:
2014-12-12
First Submit QC Date:
None
Study First Post Date:
2014-12-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-08-24
Results First Submit QC Date:
None
Results First Post Date:
2021-12-20
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-11-10
Last Update Post Date:
2021-12-20
Last Update Post Date Type:
ACTUAL